Catalyst Wire Dossier Catalyst Wire Dossier

ALN-VSP02

· Alnylam Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALN-VSP02, covering 2011-08-24 to 2012-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment [Phase 1]

See pricing